Ronald W. Dollens
chief executive officer of Guidant Corporation
Education
- Bachelor of science degree in pharmacy - Purdue University
- Master of business administration degree in marketing - Kelley School
Overview
Mr. Dollens is president and chief executive officer of Guidant Corporation, Inc. a $2.5 billion company traded on the New York and Pacific Stock Exchanges (NYSE and PCX: GDT).
Prior to the formation of Guidant, Mr. Dollens served as president of Eli Lilly and Company's Medical Devices and Diagnostics Division (MDD). In 1985, Mr. Dollens was named senior vice president of sales, marketing, and product development for Advanced Cardiovascular Systems (ACS), an MDD company headquartered in Santa Clara, California. In 1988, he became president and chief executive officer of ACS. He assumed his current post as president and chief executive officer of Guidant when the company was formed in 1994.
Mr. Dollens is a member of the board of directors of Advanced Medical Technology Association (AdvaMed, formerly HIMA), Alliance for Aging Research, Healthcare Leadership Council, Indiana Health Industry Forum, Kinetic Concepts Inc., and Beckman Coulter Corporation. Active in civic affairs, he also serves on the boards of Butler University, Eiteljorg Museum, St. Vincent Hospital Foundation, and the Indiana State Symphony Society.
Career
- Guidant Corporation - CEO
Recognition
Kelley School of Business Academy of Alumni Fellows (2002)